Trial finds drug reteplase may be another option for stroke thrombolysis
UC expert comments on study to TCT MD
The University of Cincinnati's Pooja Khatri commented to TCTMD on the RAISE trial that found drug reteplase may be a safe and effective option to treat acute ischemic stroke.
Like drugs tenecteplase and alteplase, reteplase is a clot-busting medication that was administered to patients within 4.5 hours of stroke onset during the trial. The drug was found to lead to a higher rate of excellent functional outcome compared with standard alteplase with no significant increase in symptomatic intracranial hemorrhage, other bleeding outcomes or death.
The trial “raises the possibility of another intravenous thrombolytic drug that we could use to treat acute stroke patients,” said Khatri, MD, professor, vice chair of research and division chief in the Department of Neurology & Rehabilitation Medicine at UC's College of Medicine and associate director of the UC Gardner Neuroscience Institute, noting that this is the first phase III trial to address the topic.
“It opens some doors, but we need more data to know if this is going to have a role in our armamentarium as part of our standard of care in the long run,” Khatri added.
Featured photo at top of illustration of brain with stroke symptoms. Photo/PeterSchreiber.media/iStock.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Position-specific helmets may not improve protection
March 16, 2026
Local 12 highlighted a new study by biomedical engineering researchers that looked at how well new football helmets protected players from impacts that can cause concussions.
UC biologist talks about 'pearmageddon'
March 16, 2026
WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.